Allergic Reactions After the Implantation of Drug-Eluting Stents
Authors:
- Babak AzarbalBABabak Azarbal
- Jesse W. CurrierJCJesse W. Currier
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Hypersensitivity Cases Associated With Drug-Eluting Coronary StentsJACC, 2006
- Adverse Drug Event Surveillance and Drug Withdrawals in the United States, 1969-2002Archives of internal medicine (1960), 2005
- The Research on Adverse Drug Events and Reports (RADAR) ProjectJAMA, 2005
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Adverse drug event monitoring at the food and drug administrationJournal of General Internal Medicine, 2003
- Principles of Signal Detection in PharmacovigilanceDrug Safety, 1997
- Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary ArteriesCirculation, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995